Sanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a US government department to develop a novel COVID-19 coronavirus vaccine.

But the virus’s incubation period also made rabies of interest to Pasteur—already a famous scientist in France—as a candidate for a new type of vaccine. “The time from the bite to the sickness was ...

The head of Pasteur Institute of Iran (PII) announced the export of more than 700,000 doses of the BCG vaccine to the ...

At Sanofi Pasteur, we believe in a world in which no one suffers or dies from a vaccine-preventable disease. As the world’s leading manufacturer of influenza vaccines, we know influenza is still ...

An Institut Pasteur team has developed an original vaccine platform known as MOPEVAC, that will strengthen the organization’s pandemic preparedness initiatives, with the platform’s first vaccine ...

The first rabies vaccine was produced by Émile Roux (1853-1933), a French physician and a colleague of Louis Pasteur (1822-1895). This involved growing the rabies virus in rabbits and then ...

Sanofi's vaccine maker Sanofi Pasteur is in Pocono Township. In a presentation Thursday morning, Sanofi said its ambition for Beyfortus is "blockbuster status." Beyfortus sales were €182 million ...

Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April ...

Louis Pasteur was one of the first scientists to discover the role of microorganisms in disease and how sickness could be prevented by vaccines. At the time, it was widely believed that ...